SNTI icon

Senti Biosciences
SNTI

Overview Fund Activity

45 hedge funds and large institutions have $180M invested in Senti Biosciences in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 8 closing their positions.

Holders
45
Holders Change
+3
Holders Change %
+7.14%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
6
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FTCM
1
First Trust Capital Management
Illinois
$7.68M
2
WCMNY
2
Westchester Capital Management (New York)
New York
$5.4M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$9.34M
4
Millennium Management
4
Millennium Management
New York
$8.35M
5
IPCP
5
Iron Park Capital Partners
New York
$2.23M

Top Sellers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$5.45M
2
Morgan Stanley
2
Morgan Stanley
New York
$23.5M
3
Blackstone Inc
3
Blackstone Inc
New York
$0
4
CAC
4
Cowen and Company
New York
$466K
5
NIP
5
Nicholas Investment Partners
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CF
51
Cantor Fitzgerald
New York
– – -11,973 Closed
ICM
52
III Capital Management
Florida
– – -11,039 Closed
AA
53
Ancora Advisors
Ohio
– – -3,000 Closed
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
1 2
3